Japanese encephalitis: development of new candidate vaccines (Q36441519)

14 August 2017

1 reference

title

Japanese encephalitis: development of new candidate vaccines (English)

1 reference

Japanese encephalitis virus

14 August 2017

0 references

Japanese encephalitis

1 reference

1 reference

Kaushik Bharati

1

1 reference

PubMed ID

16597211

14 August 2017

Sudhanshu Vrati

series ordinal

2

1 reference

14 August 2017

1 April 2006

1 reference

Expert Review of Anti-infective Therapy

14 August 2017

1 reference

14 August 2017

4

1 reference

14 August 2017

2

1 reference

14 August 2017

313-324

1 reference

Mosquito host-feeding patterns and implications for Japanese encephalitis virus transmission in northern Australia and Papua New Guinea

14 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Detection of west Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Complete nucleotide sequence of the Japanese encephalitis virus genome RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Flavivirus genome organization, expression, and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Dengue virus premembrane and membrane proteins elicit a protective immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Antigenic structure of the Murray Valley encephalitis virus E glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

The synthesis and maturation of a non-structural extracellular antigen from tick-borne encephalitis virus and its relationship to the intracellular NS1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Expression, purification, and characterization of the RNA 5'-triphosphatase activity of dengue virus type 2 nonstructural protein 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Genetic variation of Japanese encephalitis virus in nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Protection against Japanese encephalitis by inactivated vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Allergic reactions to Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Allergic mucocutaneous reactions to Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Development of Vero cell-derived inactivated Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Finer mapping of neutralizing epitope(s) on the C-terminal of Japanese encephalitis virus E-protein expressed in recombinant Escherichia coli system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

A 27 amino acid coding region of JE virus E protein expressed in E. coli as fusion protein with glutathione-S-transferase elicit neutralizing antibody in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

A Japanese Encephalitis Virus Peptide Present on Johnson Grass Mosaic Virus-Like Particles Induces Virus-Neutralizing Antibodies and Protects Mice against Lethal Challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Characterization of Japanese encephalitis virus envelope protein expressed by recombinant baculoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Generation and Characterization of a Mammalian Cell Line Continuously Expressing Japanese Encephalitis Virus Subviral Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Stable High-Producer Cell Clone Expressing Virus-Like Particles of the Japanese Encephalitis Virus E Protein for a Second-Generation Subunit Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

NYVAC: a highly attenuated strain of vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Efficacy studies on a canarypox-rabies recombinant virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese Encephalitis virus confers significant protection against intracerebral viral challenge without inducing detectable antiviral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Protective Mechanisms Induced by a Japanese Encephalitis Virus DNA Vaccine: Requirement for Antibody but Not CD8+ Cytotoxic T-Cell Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Immunogenicity in mice of a cationic microparticle-adsorbed plasmid DNA encoding Japanese encephalitis virus envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Inoculation of Plasmids Encoding Japanese Encephalitis Virus PrM-E Proteins with Colloidal Gold Elicits a Protective Immune Response in BALB/c Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Effect of cytokine-encoding plasmid delivery on immune response to Japanese encephalitis virus DNA vaccine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Enhancing effect of vaxfectin on the ability of a Japanese encephalitis DNA vaccine to induce neutralizing antibody in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Immunogenicity of a Japanese encephalitis DNA vaccine candidate in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodefi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.313

21 January 2018

Identifiers

DOI

10.1586/14787210.4.2.313

1 reference

14 August 2017

1 reference

PubMed ID

16597211